XJ

Active Director Director DIN 08618553
DIN 08618553 First appointment Nov 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2019
Shareholding value •••• Premium profile

About Xu Jianyi

Data last updated:

Xu Jianyi is a Director at Jansen India Medtech Private Limited (since 2019). The company operates in Healthcare. Jansen India Medtech Private Limited reported revenue of ₹30.60 Cr (FY 2025).

DIN 08618553
Primary Designation Director
Industry Healthcare
First Appointment 22 Nov 2019
Oldest Company Age 6 yrs
Largest company Jansen India Medtech Private Limited · ₹30.60 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jansen India Medtech Private Limited U85300AP2019FTC113466
Director22 Nov 20192019₹30.60 Cr (FY 2025)Active

Board colleagues of Xu Jianyi

Directorship timeline

Open interactive timeline →
Jansen India Medtech Private Limited
Premium access

Shareholding and investment profile for Xu Jianyi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Xu Jianyi

Xu Jianyi currently holds 1 directorship: Jansen India Medtech Private Limited (Director, since 22 Nov 2019, revenue ₹30.60 Cr (FY 2025)).

Xu Jianyi was first appointed on 22 Nov 2019 as Director at Jansen India Medtech Private Limited.

The current boards of Xu Jianyi's companies include Hui Xu (Jansen India Medtech Private Limited), Vivek Mehrotra (Jansen India Medtech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available